Join Our Movement to Restore Your Right to Pain Relief! #EndPainPatientAbuse
Pain Warriors Unite - (202) 792-5600
The U.S. Food and Drug Administration announced that the agency will be holding a public advisory committee meeting on June 11 and 12 to discuss safety concerns that have been raised concerning the safe prescribing and use of the higher-range doses of opioids.
The meeting will be held on
June 11, 2019, from 8 a.m. to 5 p.m. and
June 12, 2019, from 8 a.m. to 5 p.m.
The FDA meeting will include a discussion about:
The FDA intends to make background material available to the public no later than two business days before the meeting.
Comments received on or before May 28, 2019 will be provided to the committees. Comments received after that date but by June 30, 2019 will be taken into consideration by FDA.